Lepu Scientech Medical Technology (Shanghai) Co Ltd
02291
Company Profile
Business description
Lepu Scientech Medical Technology (Shanghai) Co Ltd is focused on the research and development, manufacture, and commercialization of heart disease interventional medical devices. The reporting segments of the Group are as follows: The Occluder business segment and The heart valve business segment. The company generates majority of its revenue from the Occluder segment which is engaged in the research and development, manufacturing and sales of interventional treatment series occluders for the defective congenital heart disease.
Contact
No. 258, Xinzhuan Road
1st Floor, 5th Floor Building 41
Songjiang District
Shanghai201612
CHNT: +86 2137015600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
370
Stocks News & Analysis
stocks
Ask the analyst: Where does GYG stand following its US exit?
All roads lead back home for Guzman Y Gomez.
stocks
Chart of the Week: The long term headwinds facing copper shares
The key factors challenging the bull case for copper demand.
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,007.70 | 34.00 | 0.38% |
| CAC 40 | 8,474.86 | 137.57 | 1.65% |
| DAX 40 | 25,580.88 | 540.60 | 2.16% |
| Dow JONES (US) | 52,900.07 | 594.83 | 1.14% |
| FTSE 100 | 10,652.87 | 174.53 | 1.67% |
| HKSE | 23,055.03 | 174.01 | 0.76% |
| NASDAQ | 25,832.67 | 207.36 | -0.80% |
| Nikkei 225 | 68,769.11 | 35.96 | 0.05% |
| NZX 50 Index | 13,614.17 | 31.98 | 0.24% |
| S&P 500 | 7,483.24 | 0.01 | 0.00% |
| S&P/ASX 200 | 8,806.00 | 36.70 | 0.42% |
| SSE Composite Index | 4,028.37 | 0.54 | -0.01% |